Table 1.
GO enrichment analysis (top 10) and KEGG pathways (top 5) of the DEmRNAs.
| ID | Description | Adjusted P value | Count |
|---|---|---|---|
| GO: 0001228 | DNA-binding transcription activator activity, RNA polymerase II-specific | 0.000159 | 11 |
| GO: 0010863 | Positive regulation of phospholipase C activity | 0.000742 | 5 |
| GO: 1900274 | Regulation of phospholipase C activity | 0.000742 | 5 |
| GO: 0010518 | Positive regulation of phospholipase activity | 0.001943 | 5 |
| GO: 0010517 | Regulation of phospholipase activity | 0.00266 | 5 |
| GO: 0060193 | Positive regulation of lipase activity | 0.00266 | 5 |
| GO: 0007435 | Salivary gland morphogenesis | 0.00266 | 4 |
| GO: 0007431 | Salivary gland development | 0.003219 | 4 |
| GO: 0035272 | Exocrine system development | 0.00782 | 4 |
| KEGG: hsa04010 | MAPK signaling pathway | 0.022328 | 7 |
| KEGG: hsa05215 | Prostate cancer | 0.045291 | 4 |